Politicization of the medical profession proceeds apace, at least in the treatment of individuals suffering from gender dysphoria (GD) (“transgender” patients). Just how far some medical practitioners have slid into the depths of Anti-Science is apparent from a recent interview with endocrinologist Dr. William Malone, who excoriated the dangerous but burgeoning practice of so-called gender-affirming treatment (GAT) – administering puberty-blocking drugs and cross-sex hormones to these vulnerable patients.
The complete interview merits close attention. But one of Malone’s more striking points concerned the uniqueness of the current mindset toward treating GD. In their embrace of politically correct, not to mention highly lucrative, GAT, medical professional associations and many physicians now single out GD for treatment protocols that are not and would never be acceptable in any other area of medicine.
Malone explained to interviewer Benjamin Boyce the incontrovertible scientific case against GAT. Laying out evidence from unrefuted studies (such as in Circulation and Annals of Internal Medicine), Malone cited concerns about the role of testosterone in “massive” and “profound” increases in the odds of developing heart attacks for females who identify themselves as men, (13:00), and a highly significant 2-3 fold increased rate of blood clot and stroke development for males taking estrogen (16:15).
Where else in medicine are such risks downplayed or ignored? No examples leap to mind.
But perhaps more frightening than the known risks are the unknown long-term consequences. Malone agreed with the editor-in-chief of the British Medical Journal Evidence Based Medicine in observing that the absence of long-term studies means GAT is being implemented in the context of “profound scientific ignorance” about its effects (5:00). Federally financed GAT enthusiasts claim to be examining such consequences by following patients for . . . five years. So if an 11-year-old is still happy with her “transition” and hasn’t suffered a heart attack by age 16, the researchers will declare GAT safe and effective. What happens to her at age 20 or 30 or 40 isn’t their concern.
Hacsi Horvath, a male epidemiologist who suffered through GAT and lived as a woman for 13 years before “detransitioning,” offers the darker suggestion that politicized practitioners don’t want to know the long-term consequences. “The existence of ‘regret’ and detransition is a huge thorn in their side,” he writes, “a threat to their ‘validity.’ This may be the reason that few studies bother to assess regret, or even keep good track of their patients, as is done in other areas of medicine that commonly maintain patients in long-term chronic disease care.”
But GAT activists apparently consider their area of practice exempt from the usual rules.
Click here to read more.
SOURCE: Christian Post, Jane Robbins